[go: up one dir, main page]

RU2003112906A - METHOD FOR TREATMENT OF ACANTOLIC BUBBLE - Google Patents

METHOD FOR TREATMENT OF ACANTOLIC BUBBLE

Info

Publication number
RU2003112906A
RU2003112906A RU2003112906/14A RU2003112906A RU2003112906A RU 2003112906 A RU2003112906 A RU 2003112906A RU 2003112906/14 A RU2003112906/14 A RU 2003112906/14A RU 2003112906 A RU2003112906 A RU 2003112906A RU 2003112906 A RU2003112906 A RU 2003112906A
Authority
RU
Russia
Prior art keywords
acantolic
bubble
treatment
mexidol
cytostatics
Prior art date
Application number
RU2003112906/14A
Other languages
Russian (ru)
Other versions
RU2233163C1 (en
Inventor
Галина Александровна Пантелеева
Рената Васильевна Михайлушкина
Original Assignee
Государственное учреждение "Нижегородский научно-исследовательский кожно-венерологический институт"
Filing date
Publication date
Application filed by Государственное учреждение "Нижегородский научно-исследовательский кожно-венерологический институт" filed Critical Государственное учреждение "Нижегородский научно-исследовательский кожно-венерологический институт"
Priority to RU2003112906/14A priority Critical patent/RU2233163C1/en
Priority claimed from RU2003112906/14A external-priority patent/RU2233163C1/en
Application granted granted Critical
Publication of RU2233163C1 publication Critical patent/RU2233163C1/en
Publication of RU2003112906A publication Critical patent/RU2003112906A/en

Links

Claims (1)

Способ лечения больных акантолитической пузырчаткой, заключающийся в назначении кортикостероидных препаратов и цитостатиков, отличающийся тем, что дополнительно вводят 5%-ный раствор мексидола по 2 мл внутримышечно 2 раза в сутки в течение 10 дней.A method of treating patients with acantholytic pemphigus, which consists in the appointment of corticosteroid drugs and cytostatics, characterized in that it is additionally administered a 5% solution of Mexidol 2 ml intramuscularly 2 times a day for 10 days.
RU2003112906/14A 2003-04-30 2003-04-30 Method for treatment of acantholytic pemphigus RU2233163C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003112906/14A RU2233163C1 (en) 2003-04-30 2003-04-30 Method for treatment of acantholytic pemphigus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003112906/14A RU2233163C1 (en) 2003-04-30 2003-04-30 Method for treatment of acantholytic pemphigus

Publications (2)

Publication Number Publication Date
RU2233163C1 RU2233163C1 (en) 2004-07-27
RU2003112906A true RU2003112906A (en) 2004-11-20

Family

ID=33414404

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003112906/14A RU2233163C1 (en) 2003-04-30 2003-04-30 Method for treatment of acantholytic pemphigus

Country Status (1)

Country Link
RU (1) RU2233163C1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2321395C1 (en) * 2006-06-01 2008-04-10 Федеральное государственное учреждение "Нижегородский научно-исследовательский кожно-венерологический институт Федерального агентства по здравоохранению и социальному развитию" Method for treating patients for acantholytic bladderwort
RU2356552C1 (en) * 2007-12-24 2009-05-27 Ольга Александровна Попова Antipsoriatic agent
RU2356536C1 (en) * 2007-12-24 2009-05-27 Ольга Александровна Попова Skin diseases treatment agent
RU2391984C1 (en) * 2009-01-11 2010-06-20 Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "УрНИИДВиИ Росмедтехнологий") Acantholytic pemphigus treatment method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282225B6 (en) * 1995-12-28 2001-12-03 Welfide Corporation Use of 2-amino-2[2-(octylphenyl)ethyl]-propane-1,3-diol or its pharmaceutically acceptable additive salt with acid for production of pharmaceutical preparation
SI0990440T1 (en) * 1997-02-27 2009-04-30 Novartis Ag PHARMACEUTICAL COMPOSITION COMPRISING 2-AMINO-2-?á2-(4-OCTYLPHENYL)ETHYL?åPROPANE-1,3-DIOL, A LECITHIN AND A SACCHARIDE
NZ509901A (en) * 1998-07-23 2003-10-31 Yeda Res & Dev Treatment of autoimmune conditions terpolymers consisting of three amino acids selected from glu, ala, lys or tyr
HRP20010309B1 (en) * 1998-12-23 2005-06-30 Idea Ag Improved formulation for topical non-invasive application in vivo

Similar Documents

Publication Publication Date Title
CY1112184T1 (en) PYRIDOXAMINE FOR USE IN TREATMENT OF DIABETIC Nephropathy in Type II Diabetes
NO20055173L (en) Pharmaceutical combination combination comprising modafinil and another drug
RU2003112906A (en) METHOD FOR TREATMENT OF ACANTOLIC BUBBLE
DE60213234D1 (en) 4- (PENYLPIPERIDIN-4-YLIDENETHYL) BENZAMID DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PAIN, FEAR STORIES OR DISEASES OF THE STOMACH DARM TRAKTS
RU2003118497A (en) METHOD FOR TREATING DISEASES OF Mucous membranes
RU2006146326A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS C
RU2002105274A (en) Method for immunorehabilitation of patients with chronic bronchitis
JP2005506959A5 (en)
DE602004016547D1 (en) 1,4-DIHYDROPYRIDINE COMPOUNDS, PHARMACEUTICAL COMPOUNDS, AND METHOD FOR THE TREATMENT OF CARDIAC DISORDER
RU2002116408A (en) Method for reperfusion therapy of patients with acute myocardial infarction
DE60313208D1 (en) PHENYL-PIPERIDINE-4-YLIDEN-METHYL-BENZAMID DERIVATIVES FOR THE TREATMENT OF PAIN OR STOMACH DARM DISEASES
RU2003124971A (en) METHOD FOR TREATING PATIENTS WITH NEUROTIC AND SOMATOFORM DISORDERS
RU2006119262A (en) METHOD FOR TREATING PATIENTS WITH ACANTOLYTIC BUBBLE
DE60327249D1 (en) ANTHRANILIC ACID AMIDE AND ITS PHARMACEUTICAL USE
RU2002113978A (en) A method of stimulating motor activity of the intestine
RU2002130727A (en) METHOD FOR TREATING CHILDREN AND ADOLESCENTS WITH LATENT TUBERCULOSIS INFECTION
RU2002111257A (en) METHOD FOR TREATING PATIENTS WITH ISCHEMIC STROKE
EA200701920A1 (en) USE OF PHENYLACETAL DERIVATIVES FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF DISEASE HIPPEL-LINDAU VON (VHL)
RU2002109173A (en) A method for the treatment of degenerative diseases of the retina
RU2001126651A (en) A method for the treatment of edematous maculopathy
RU2002113511A (en) A method for the treatment of odontogenic adenoflegmon
DE602004015321D1 (en) 1,4-DIHYDROPYRIDINE COMPOUNDS, PHARMACEUTICAL COMPOUNDS, AND METHOD FOR THE TREATMENT OF CARDIAC DISORDER
IS8356A (en) Medications, methods and dose control for the treatment and prevention of acute coronary heart disease
RU2003138011A (en) METHOD FOR TREATING CHRONIC PYELONEPHRITIS
RU2003106097A (en) METHOD FOR THE CONTROLLED REDUCTION OF THE AGGREGATION ACTIVITY OF THROMBOCYTES IN THE EXPERIMENT